127 related articles for article (PubMed ID: 1717527)
1. Keratinocyte expression of CD36 antigen in benign and malignant epidermal cell-derived tumours.
Allen MH; Barker JN; MacDonald DM
J Cutan Pathol; 1991 Jun; 18(3):198-203. PubMed ID: 1717527
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of major histocompatibility complex (MHC) antigens by epidermal tumours.
Markey AC; Churchill LJ; MacDonald DM
J Cutan Pathol; 1990 Apr; 17(2):65-71. PubMed ID: 2187024
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
[TBL] [Abstract][Full Text] [Related]
4. Altered keratin expression in benign and malignant skin diseases revealed with monoclonal antibodies.
Kariniemi AL; Virtanen I
Am J Dermatopathol; 1989 Jun; 11(3):202-8. PubMed ID: 2471415
[TBL] [Abstract][Full Text] [Related]
5. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte and epidermal leukocyte expression of CD36 (OKM5) in benign and malignant skin diseases.
Lisby S; Ralfkiaer E; Hansen ER; Vejlsgaard GL
Acta Derm Venereol; 1990; 70(1):18-22. PubMed ID: 1689091
[TBL] [Abstract][Full Text] [Related]
7. The basal lamina in basal cell carcinoma, Bowen's disease, squamous cell carcinoma and keratoacanthoma: an immunoperoxidase study using an antibody to type IV collagen.
McArdle JP; Roff BT; Muller HK; Murphy WH
Pathology; 1984 Jan; 16(1):67-72. PubMed ID: 6371685
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of Langerhans cells and expression of class II antigens on keratinocytes in malignant and benign epithelial tumors of the skin: an immunohistopathologic study with monoclonal antibodies.
Chen HD; Zhao YM; Sun G; Yang CY
J Am Acad Dermatol; 1989 Jun; 20(6):1007-14. PubMed ID: 2474010
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of Langerhans cells in actinic keratosis, Bowen's disease, keratoacanthoma, squamous cell carcinoma and basal cell carcinoma.
McArdle JP; Knight BA; Halliday GM; Muller HK; Rowden G
Pathology; 1986 Apr; 18(2):212-6. PubMed ID: 3763243
[TBL] [Abstract][Full Text] [Related]
10. Functional thrombomodulin expression on epithelial skin tumours as a differentiation marker for suprabasal keratinocytes.
Mizutani H; Ohyanagi S; Hayashi T; Groves RW; Suzuki K; Shimizu M
Br J Dermatol; 1996 Aug; 135(2):187-93. PubMed ID: 8881658
[TBL] [Abstract][Full Text] [Related]
11. Basal cell and squamous cell carcinomas. Clinico-histological features.
Annessi G; Baliva G
Ann Ist Super Sanita; 1996; 32(1):29-36. PubMed ID: 8804183
[TBL] [Abstract][Full Text] [Related]
12. Keratinocyte expression of OKM5 antigen in inflammatory cutaneous disease.
Barker JN; Markey AC; Allen MH; MacDonald DM
Br J Dermatol; 1989 May; 120(5):613-8. PubMed ID: 2474314
[TBL] [Abstract][Full Text] [Related]
13. Non-melanoma skin cancer: an overindulged circumlocution articulating keratinocytic cancer.
Ruocco V; Ruocco E; Brunetti G; Schwartz RA
Int J Dermatol; 2014 Mar; 53(3):e228-9. PubMed ID: 23565967
[No Abstract] [Full Text] [Related]
14. Histology of melanoma and nonmelanoma skin cancer.
Mueller CS; Reichrath J
Adv Exp Med Biol; 2008; 624():215-26. PubMed ID: 18348459
[No Abstract] [Full Text] [Related]
15. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
Bordbar A; Dias D; Cabral A; Beck S; Boon ME
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
[TBL] [Abstract][Full Text] [Related]
16. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
[TBL] [Abstract][Full Text] [Related]
17. Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes.
Takahara M; Chen S; Kido M; Takeuchi S; Uchi H; Tu Y; Moroi Y; Furue M
J Cutan Pathol; 2009 Jun; 36(6):668-74. PubMed ID: 19515046
[TBL] [Abstract][Full Text] [Related]
18. Localization of MGSA/GRO protein in cutaneous lesions.
Tettelbach W; Nanney L; Ellis D; King L; Richmond A
J Cutan Pathol; 1993 Jun; 20(3):259-66. PubMed ID: 8366215
[TBL] [Abstract][Full Text] [Related]
19. Selective expression of immune-associated surface antigens by keratinocytes in irritant contact dermatitis.
Willis CM; Stephens CJ; Wilkinson JD
J Invest Dermatol; 1991 Apr; 96(4):505-11. PubMed ID: 1706746
[TBL] [Abstract][Full Text] [Related]
20. Skin tumors.
Traub EF
Cutis; 1976 Sep; 18(3):366-72. PubMed ID: 189972
[No Abstract] [Full Text] [Related]
[Next] [New Search]
